In The News

Learn About Cord Blood



Bookmark and Share

Client Testimonials

“I couldn't believe a cord blood bank would really care and provide the customer support you offered our family.

Thanks for setting the bar so high.”

Joyce A., NM

#
# Some Things Are Worth Holding Onto . . . Cord Blood Is One Of Them.  

In The News

Articles

Drug Week

April 24, 2009

CORD BLOOD;
Bio-Matrix Scientific Group, Inc.

CEO Tells LifeNews.com: Stem Cell Treatments from Umbilical Cord Blood Among Fastest Growing Therapy for Cancer and Leukemia Patients

SECTION: EXPANDED REPORTING; Pg. 178

LENGTH: 565 words
(BULLETIN BOARD: BMSN) (http://www.bmsn.us/) announced that it is highlighted in an Adult Stem Cell Trend Report published in LifeNews.com (http://www.lifenews.com/) on April 6, 2009 that provides an analysis for stem cell treatments from umbilical cord blood as being one of the fastest growing therapy groups. According to David Koos, Chairman and CEO of BMSN, "Umbilical cord blood has been and proven to be clinically effective for conditions including cancers, leukemia, and sickle cell anemia." BMSN is a San Diego-based biotechnology research and development company focused on cord blood and peripheral adult stem cells. The company has one of the leading commercial cryogenic stem cell banking facilities in the nation (see also Cord Blood).


Koos said the market analysis in the LifeNews.com Trend Report, provided by Robin Young, CFA and CEO of RRY Publications LLL, ("Stem Cell Summit Executive Summary 2009-2019" http://www.ryortho.com/, click-on Bookstore), also stated: "In fact, stem cell transplantation recently has overtaken bone marrow cell transplantation in total number of treatments. As these therapies become more publicized, more effective, and more wide-reaching, the demand for stem cells will grow from two primary factors: increasing numbers of transplant patients, and increasing numbers of parents banking cord blood as a sort of 'biological insurance.'"
The Adult Stem Cell Trend Report, "Research and Therapeutics Advancing Regenerative Medicine, Buoyed by Federal Government and Big Pharmaceutical Companies," by New York City-based author and writer Sally Robbins, also reports on Young's forecast: "Worldwide estimates show the market for cord blood processing and banking will grow by 25% over the next five years (approaching $450 million annually for cord blood processing), driven by surging demand in the U.S. and Western Europe (where an estimated one-quarter of all newborns will have banked cord blood) and exploding demand in India, China and Latin America - where processing is just beginning to take off."

 

In addition, the report highlights cord blood technology advancements since the first cord blood transplantation in the world 21 years ago, in which the recipient continues in good

 

 

 
#